Ignite Creation Date:
2024-05-06 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 12:01 PM
Study NCT ID:
NCT02754011
Status:
COMPLETED
Last Update Posted:
2023-12-07
First Post:
2016-02-19
Brief Title:
Phase I Evaluating the Combination of RibociclibCapecitabine in Locally AdvancedMetastatic Breast Cancer HER2 Negative
Sponsor:
UNICANCER
Organization:
UNICANCER
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-02-19
First Submit QC Date:
April 26 2016
Study First Post Date:
2016-04-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-06
Last Update Post Date:
2023-12-07
Last Update Post Date Type:
ACTUAL